Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
Sponsor: Baxter Healthcare Corporation
Terminated
Limited patient recruitment
Other terminated trials from Baxter Healthcare Corporation
- Neuromuscular Diseases · Phase NA · Feb 2024
- Wound of Skin · Nov 2023
- Critical Illness · Phase NA · Aug 2022
- Acute Heart Failure · Oct 2021
- Atrial Fibrillation · Dec 2020
More terminations from Baxter Healthcare Corporation
This NA trial investigates Functionally Anuric and Hemodialysis/Peritoneal Dialysis and is currently terminated or withdrawn. Baxter Healthcare Corporation leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- Davita Clinical Research
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.